Immune to Cancer: The CRI Blog
-
Five Spring Fundraising Ideas for 2021
Spring equinox marks a moment of renewal. Why not choose a personal goal to invest in yourself…
-
Head and Neck Cancer Awareness Month: 2021 Immunotherapy Research Updates
This April for Head and Neck Cancer Awareness Month, we look at new research, new treatments, and…
-
What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design
Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.
-
Qué esperar de la inmunoterapia contra el cáncer en 2021: COVID-19, biomarcadores y modelos de ensayos clínicos
El Dr. Kunle Odunsi comparte sus reflexiones sobre el futuro en el campo de la inmunoterapia contra…
-
Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer
CRI highlights some of the many women who are and have been integral to our organization and…
-
Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer
Presentamos a algunas de las muchas mujeres que fueron y son fundamentales para el CRI y la…
-
Charting the Course Ahead: CRI’s CEO Weighs in on 2020 and the Bright Path Forward
CRI CEO Jill O’Donnell-Tormey, PhD, on how the organization as well as cancer research and treatment are…
-
Marcando el rumbo a seguir: la Directora Ejecutiva del CRI analiza 2020 y el prometedor futuro
La Directora Ejecutiva del CRI, la Dra. Jill O’Donnell-Tormey, Ph. D., habla sobre los avances de la…
-
For the Love of Burpees and Cancer Research: How a ’21 Challenger is Pushing Himself for a Cancer-Free Future
How ’21 Challenger Salvatore Toner is pushing himself and his community for a future immune to cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.